[EDAP] EDAP TMS S.A.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization: 80.39 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 3.32 Change: 0.03 (0.91%)
Ext. hours: Change: 0 (0%)

chart EDAP

Refresh chart

Strongest Trends Summary For EDAP

EDAP is in the medium-term up 79% in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: EDAP TMS S.A., through its subsidiaries, develops, produces, and markets minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services. The High Intensity Focused Ultrasound division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It also offers Ablatherm, a HIFU-based device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. In addition, this division leases equipment; sells disposables and spare parts; and offers maintenance services. The Urology Devices and Service division develops, markets, manufactures, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding25.44 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow-57.59 ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.04 M Cash From Investing Activities-1.03 M Cash From Operating Activities-1.01 M Gross Profit2.58 M
Net Profit-2.44 M Operating Profit-620 K Total Assets32.15 M Total Current Assets26.61 M
Total Current Liabilities12.16 M Total Debt5.25 M Total Liabilities17.01 M Total Revenue6.22 M
Technical Data
High 52 week5.31 Low 52 week1.51 Last close4.7 Last change3.98%
RSI57.25 Average true range0.27 Beta0.44 Volume60.6 K
Simple moving average 20 days3.83% Simple moving average 50 days21.89% Simple moving average 200 days39.57%
Performance Data
Performance Week-2.69% Performance Month16.34% Performance Quart76.69% Performance Half-8.38%
Performance Year83.59% Performance Year-to-date154.05% Volatility daily2.97% Volatility weekly6.64%
Volatility monthly13.61% Volatility yearly47.15% Relative Volume248.4% Average Volume204.04 K
New High New Low

News

2020-05-13 16:35:00 | EDAP Reports First Quarter 2020 Results and Provides Operational Update

2020-05-12 16:35:00 | EDAP ANNOUNCES EXCLUSIVE WORLDWIDE DISTRIBUTION RIGHTS TO EXACT IMAGING’S MICRO-ULTRASOUND TECHNOLOGIES

2020-05-06 08:30:00 | EDAP TMS SA to Announce First Quarter 2020 Financial Results on May 13, 2020

2020-05-04 08:22:04 | How Does EDAP TMS S.A. NASDAQ:EDAP Affect Your Portfolio Volatility?

2020-04-04 08:50:07 | Time To Worry? One Analyst Just Downgraded Their EDAP TMS S.A. NASDAQ:EDAP Outlook

2020-03-31 06:30:00 | EDAP TMS SA to Host Earnings Call

2020-03-30 16:35:00 | EDAP Reports Record Full Year 2019 Results and Provides Operational Update

2020-03-30 07:00:43 | Can EDAP TMS S.A.'s NASDAQ:EDAP ROE Continue To Surpass The Industry Average?

2020-03-24 08:35:00 | EDAP TMS SA to Announce Fourth Quarter and Year Ended December 31, 2019 Financial Results on Monday, March 30, 2020

2020-03-17 08:35:00 | EDAP Issues Letter to Shareholders Providing an Update on COVID-19 and the Potential Impact to Operations

2020-02-18 08:25:00 | EDAP Showcases Focal One at the 12th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer  

2020-01-29 08:30:00 | EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

2020-01-09 08:30:00 | EDAP Issues Letter to Shareholders

2019-12-31 11:46:45 | Is Now An Opportune Moment To Examine EDAP TMS S.A. NASDAQ:EDAP?

2019-12-20 10:45:52 | Hedge Funds Have Never Been This Bullish On EDAP TMS S.A. EDAP

2019-12-19 08:30:00 | EDAP Announces Publication of Focal One® Endometriosis Study in the Journal Ultrasound in Obstetrics & Gynecology

2019-11-26 08:29:00 | EDAP Announces First Focal One® HIFU treatments at Farrer Park Hospital in Singapore

2019-11-18 09:00:02 | EDAP TMS S.A. EDAP Moves to Buy: Rationale Behind the Upgrade

2019-11-14 06:01:32 | What You Must Know About EDAP TMS S.A.'s NASDAQ:EDAP Beta Value

2019-11-13 16:32:00 | EDAP Reports 2019 Third Quarter and Nine Months Results

2019-10-30 08:00:00 | EDAP to Introduce New Endo-UP® Endourology Platform During the 2019 World Congress of Endourology

2019-10-24 08:00:00 | EDAP TMS SA to Announce Third Quarter and Nine Months 2019 Financial Results on Wednesday, November 13, 2019

2019-09-30 07:33:09 | What EDAP TMS S.A.'s NASDAQ:EDAP ROE Can Tell Us

2019-09-26 08:31:12 | Will EDAP TMS Continue to Surge Higher?

2019-09-20 10:40:02 | Top Ranked Momentum Stocks to Buy for September 20th

2019-09-06 10:07:02 | EDAP TMS S.A. EDAP Shares March Higher, Can It Continue?

2019-09-06 09:00:01 | EDAP TMS S.A. EDAP Upgraded to Strong Buy: Here's Why

2019-08-30 07:39:59 | Why EDAP TMS S.A.’s NASDAQ:EDAP Use Of Investor Capital Doesn’t Look Great

2019-08-29 07:38:20 | The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings

2019-08-28 16:44:29 | EDAP Reports 2019 Second Quarter Results

2019-07-26 12:31:10 | EDAP TMS NASDAQ:EDAP May Be Weighed Down By Its Debt

2019-07-25 08:00:00 | EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019

2019-06-10 08:30:00 | Edap Tms: EDAP Announces Positive Outcome from CPT Panel for HIFU Reimbursement in the U.S.

2019-05-15 16:35:00 | EDAP Reports 2019 First Quarter Results

2019-05-14 17:14:00 | EDAP TMS Expected to Earn 2 Cents a Share

2019-05-02 08:00:00 | EDAP TMS SA to Announce First Quarter 2019 Financial Results on Wednesday, May 15, 2019

2019-04-29 08:01:08 | EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting

2019-04-26 14:49:48 | Introducing EDAP TMS NASDAQ:EDAP, The Stock That Zoomed 117% In The Last Year

2019-04-10 08:39:12 | EDAP TMS EDAP Looks Good: Stock Adds 7.9% in Session

2019-04-02 17:50:36 | Dow Jones Falls on Tuesday

2019-04-02 07:30:37 | The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial

2019-04-02 06:30:00 | EDAP TMS SA Sponsored ADR to Host Earnings Call

2019-04-01 16:35:00 | EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results

2019-04-01 08:00:54 | EDAP TMS SA : University of Chicago Medicine Becomes First Hospital in the Midwest to Acquire Breakthrough Focal One® HIFU Advanced Robotic Technology for Prostate Cancer Treatment

2019-03-21 16:35:46 | EDAP TMS SA : EDAP TMS SA to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, April 1, 2019

2019-03-04 08:01:09 | EDAP TMS SA : HIFU Pioneer Houston Methodist Hospital Acquires EDAP's Next Generation Focal One HIFU System

2019-02-05 08:00:58 | EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP's Breakthrough Focal One® HIFU Technology

2019-01-22 11:59:02 | What Kind Of Shareholders Own EDAP TMS S.A. NASDAQ:EDAP?

2019-01-18 08:01:00 | EDAP TMS SA : EDAP Announces the Purchase of Focal One® HIFU by Maimonides Medical Center, Brooklyn, NY

2019-01-14 08:00:42 | EDAP TMS SA : EDAP Announces Sales of Two Additional Focal One® Devices in Brazil